in the Short-Term and Long-Term Absence of Estrogens Receptor Content of MCF-7 Human Breast Cancer Cells Grown Proliferation , Hormonal Responsiveness , and Estrogen Updated

We have examined the effect of short-term and long-term growth in the absence of estrogens on the proliferation rate and estrogen and antiestrogen responsiveness of MCF-7 human breast cancer cells. The removal of phenol red, the pH indicator in tissue culture medium that is weakly estrogenic (Y. Berthois et al., Proc. Nati. Acad. Sci. USA, 83: 2496-2500, 1986), immediately slows the cell proliferation rate, and MCF-7 cells grown in phenol red-free medium with charcoal dextrantreated serum for periods up to 1 mo maintain this reduced rate of cell proliferation. In these short-term phenol red-withdrawn cells, estradici stimulates proliferation markedly and reproducibly, and antiestrogens inhibit estrogen-stimulated proliferation. Antiestrogens by themselves appear as partial agonists/antagonists; at low concentrations they stim ulate proliferation weakly, but they show no stimulation at the high concentrations where they fully inhibit estrogen-stimulated proliferation. In contrast to the short-term phenol red-withdrawn cells, cells maintained for several months (5 to 6 mo) in the apparently complete absence of estrogens (no phenol red, with charcoal dextran-treated calf serum) show a markedly increased basal rate of cell proliferation; estradiol is unable to increase this rate of proliferation further, but antiestrogens are able to decrease proliferation. This change in growth pattern is associated with a 3-fold increase in cellular estrogen receptor levels. Despite their differ ing basal growth rates, cells grown in either the short-term (<1 mo) or long-term (>6 mo) absence of estrogens both have progesterone receptor levels that are very low and, in both cases, estradiol increases progester one receptor levels markedly. Thus, under long-term estrogen-free con ditions, there is a dissociation between the stimulation of cell proliferation and of specific protein synthesis (progesterone receptor) by estrogen. The increase in the cell proliferation rate observed in cells grown in the longterm absence of estrogen may reflect altered regulation of growth factor production or altered sensitivity to growth factors in the medium or produced by the cells themselves. Hence, these breast cancer cells adapt significantly to long-term growth in estrogen-free conditions, an obser vation that may be relevant to understanding the growth of hormoneresponsive human breast cancers in vivo.

[1]  B. Katzenellenbogen,et al.  Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites , 1985, Breast Cancer Research and Treatment.

[2]  B. Katzenellenbogen,et al.  Antiestrogen stimulation of the production of a 37,000 molecular weight secreted protein and estrogen stimulation of the production of a 32,000 molecular weight secreted protein in MCF-7 human breast cancer cells. , 1987, Endocrinology.

[3]  M. Lippman,et al.  Estrogen inhibition of a Mr 39,000 glycoprotein secreted by human breast cancer cells. , 1987, Cancer research.

[4]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[5]  R. Dickson,et al.  Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. , 1986, Science.

[6]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Katzenellenbogen,et al.  Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells. , 1986, Cancer research.

[8]  R. Dickson,et al.  Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. , 1986, Endocrinology.

[9]  B. Katzenellenbogen,et al.  Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling. , 1985, Endocrinology.

[10]  C. Sonnenschein,et al.  Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells. , 1985, Life sciences.

[11]  M. Lippman,et al.  Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. , 1985, Cancer research.

[12]  C. Osborne,et al.  Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. , 1985, Cancer research.

[13]  R. Sutherland,et al.  Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. , 1984, European journal of cancer & clinical oncology.

[14]  M. Lippman,et al.  The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor. , 1984, Endocrinology.

[15]  R. King,et al.  Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation , 1984, The Journal of cell biology.

[16]  A. Krust,et al.  Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. , 1984, The Journal of biological chemistry.

[17]  B. Katzenellenbogen,et al.  Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. , 1984, Endocrinology.

[18]  P. Darbre,et al.  Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. , 1984, Cancer research.

[19]  R. Furlanetto,et al.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. , 1984, Cancer research.

[20]  B. Katzenellenbogen,et al.  Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. , 1984, Endocrinology.

[21]  B. Katzenellenbogen,et al.  Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. , 1984, Cancer research.

[22]  G. Peters,et al.  Androgen regulation of cell proliferation and expression of viral sequences in mouse mammary tumour cells , 1983, Nature.

[23]  C. D. Jones,et al.  Antagonism of estrogen action with a new benzothiophene derived antiestrogen. , 1983, Life sciences.

[24]  B. Katzenellenbogen,et al.  ANTIESTROGEN BASICITY‐ACTIVITY RELATIONSHIPS: A COMPARISON OF THE ESTROGEN RECEPTOR BINDING AND ANTIUTEROTROPHIC POTENCIES OF SEVERAL ANALOGS OF (Z)‐1,2‐DIPHENYL‐1‐(4‐(2‐(DIMETHYLAMINO)ETHOXY)PHENYL)‐1‐BUTENE (TAMOXIFEN, NOLVADEX) HAVING ALTERED BASICITY , 1982 .

[25]  J. MacIndoe,et al.  The specific binding of estradiol and estrone and the subsequent distribution of estrogen-receptor complexes within MCF-7 human breast cancer cells , 1982, Steroids.

[26]  B. Katzenellenbogen,et al.  Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. , 1982, Cancer research.

[27]  R. King,et al.  Correlation of growth properties and morphology with hormone responsiveness of mammary tumor cells in culture. , 1981, Cancer research.

[28]  C. Osborne,et al.  Epidermal growth factor stimulation of human breast cancer cells in culture. , 1980, Cancer research.

[29]  L. Black,et al.  Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice. , 1980, Life sciences.

[30]  B. Katzenellenbogen,et al.  Estrogen and antiestrogen action in reproductive tissues and tumors. , 1979, Recent progress in hormone research.

[31]  W. McGuire,et al.  Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. , 1978, The Journal of biological chemistry.

[32]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.

[33]  M. Lippman,et al.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.

[34]  W. McGuire,et al.  MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.

[35]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[36]  J. Heuson,et al.  Growth-stimulating effect of Nafoxidine on rat mammary tumor after ovariectomy. , 1973, European journal of cancer.